Molecular and Cellular Biochemistry

, Volume 147, Issue 1–2, pp 29–34

Progression of heart failure: A role for interstitial fibrosis

  • Hani N. Sabbah
  • Victor G. Sharov
  • Michael Lesch
  • Sidney Goldstein
Part I: Extracellular Matrix and Cardiocyte Interaction
  • 306 Downloads

Abstract

Progressive deterioration of left ventricular (LV) function is a characteristic feature of the heart failure (HF) state. The mechanism or mechanisms responsible for this hemodynamic deterioration are not known but may be related to progressive intrinsic dysfunction, degeneration and loss of viable cardiocytes. In the present study, we tested the hypothesis that accumulation of collagen in the cardiac interstitium (reactive interstitial fibrosis, RIF), known to occur in HF, results in reduced capillary density (CD=capillary/fiber ratio) and increased oxygen diffusion distance (ODD) which can lead to hypoxia and dysfunction of the collagen encircled myocyte. Studies were performed in LV tissue obtained from 10 dogs with chronic HF (LV ejection fraction 26±1%) produced by multiple sequential intracoronary, microembolizations. In each dog, CD and ODD were evaluated in LV regions that manifested severe RIF (volume fraction 16±2%) and in LV regions of little or no RIF (volume fraction 4±1%). In regions of severe RIF, CD was significantly decreased compared to regions of no RIF (0.92±0.02 vs. 1.05±0.03) (P<0.03). Similarly, ODD was significantly increased in regions of severe RIF compared to regions of no RIF (15.3±0.4 vs. 12.2±0.3 μm) (P<0.001). These data suggest that in dogs with chronic HF, constituent myocytes of LV regions which manifest severe RIF may be subjected to chronic hypoxia; a condition that can adversely impact the function and viability of the collagen encircled cardiocyte.

Key words

heart failure ventricular function interstitial fibrosis coronary microcirculation 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ertl G, Kochsiek K: Development, early treatment, and prevention of heart failure. Circulation 87: IV-1–IV-2, 1993Google Scholar
  2. 2.
    Mckee PA, Castelli WP, Mcnamara PM, Kannel WB: The natural history of congestive heart failure: the Framingham study. N Engl J Med 285: 1441–1446, 1971PubMedGoogle Scholar
  3. 3.
    Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, Dolan N, Edens TR, Ahn S, Kinan D, Howe DM, Kilcoyne L, Metherall J, Benedict C, Yusuf S, Pouleur H: Effects of the angiotensin converting enzyme inhibitor enalapril on long-term progression of left ventricular dysfunction in patients with heart failure. Circulation 86: 431–438, 1991Google Scholar
  4. 4.
    Anversa P, Olivetti G, Capasso JM: Cellular basis of ventricular remodeling after myocardial infarction. Am J Cardiol 68: 7D-16D, 1991PubMedGoogle Scholar
  5. 5.
    Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E: Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 319: 80–86, 1988PubMedGoogle Scholar
  6. 6.
    Levine TB, Francis GS, Goldsmith SR, Simon AB, Cohn JN: Activity of the sympathetic nervous system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol 49: 1659–1666, 1982PubMedGoogle Scholar
  7. 7.
    Curtiss C, Cohn JN, Vrobel T, Franciosa JA: Role of the reninangiotensin system in the systemic vasoconstriction of chronic congestive heart failure. Circulation 58: 763–770, 1978PubMedGoogle Scholar
  8. 8.
    Sharov VG, Sabbah HN, Shimoyama H, Ali AS, Levine TB, Lesch M, Goldstein S: Abnormalites of contractile structures in viable myocytes of the failing heart. Intl J Cardiol 43: 287–297, 1994Google Scholar
  9. 9.
    Sabbah HN, Sharov VG, Riddle JM, Kono T, Lesch M, Goldstein S: Mitochondrial abnormalities in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol 24: 1333–1347, 1992PubMedGoogle Scholar
  10. 10.
    Schaper J, Hein S: The structural correlate of reduced cardiac function in human dilated cardiomyopathy. Heart Failure 9: 95–111, 1993Google Scholar
  11. 11.
    Sabbah HN, Stein PD, Kono T, Gheorghiade M, Levine TB, Jafri S, Hawkins ET, Goldstein S: A canine model of chronic heart failure produced by multiple sequential coronary microembolizations. Am J Physiol 260: H1379-H1384 1991PubMedGoogle Scholar
  12. 12.
    Grossman W: Clinical measurements of vascular resistance and assessment of vasodilator drugs. In: W. Grossman and D.S. Baim (eds). Cardiac Catheterization, Angiography and Intervention. Lea and Febiger, Philadelphia, 1991, pp 143–151Google Scholar
  13. 13.
    Dodge HT, Sandler H, Baxley WA, Hawley RR: Usefulness and limitations of radiographic methods for determining left ventricular volume. Am J Cardiol 18: 10–24, 1966PubMedGoogle Scholar
  14. 14.
    Sabbah HN, Hansen-Smith F, Sharov VG, Kono T, Lesch M, Gengo PG, Steffen RP, Levine TB, Goldstein S: Decreased proportion of type I myofibers in skeletal muscle of dogs with chronic heart failure. Circulation 87: 1729–1737, 1993PubMedGoogle Scholar
  15. 15.
    Hansen-Smith FM, Watson L, Lu DY, Goldstein I: Griffonia simlicifolia I: Fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle. Microvasc Res 36: 199–215, 1988PubMedGoogle Scholar
  16. 16.
    Rakusan K: Oxygen in Heart Muscle. Charles C. Thomas, Springfield, 1971, pp 22–33, 66–71Google Scholar
  17. 17.
    Dzau VJ: Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 77: I-4–I-13, 1988Google Scholar
  18. 18.
    Packer M: The neurohormonal hypothesis: A theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 20: 248–154, 1992PubMedGoogle Scholar
  19. 19.
    Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT: Cardiac myocyte necrosis induced by angiotensin-II. Circ Res 69: 1185–1195, 1991PubMedGoogle Scholar
  20. 20.
    Mann DL, Kent RL, Parsons B, Cooper G: Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 85: 790–804, 1992PubMedGoogle Scholar
  21. 21.
    Benjamin IJ, Jalil JE, Tan LB, Cho K, Weber KT, Clark WA: Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 65: 657–670, 1989PubMedGoogle Scholar
  22. 22.
    Meerson FZ: The myocardium in hyperfunction, hypertrophy and heart failure. Circ Res 25: 1–163, 1963Google Scholar
  23. 23.
    Weber KT, Brilla CG: Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83: 1849–1865, 1991PubMedGoogle Scholar
  24. 24.
    Brilla CG, Weber KT: Reactive and reparative myocardial fibrosis in arterial hypertension. Cardiovasc Res 26: 671–677, 1992PubMedGoogle Scholar
  25. 25.
    Shimoyama H, Sabbah HN, Sharov VG, Cook J, Lesch M, Goldstein S: Accumulation of interstitial collagen in the failing left ventricular myocardium is associated with increased anaerobic metabolism among affected cardiomyocytes (Abstr). J Am Coll Cardiol, Special Issue: 98A, 1994Google Scholar
  26. 26.
    Sharov VG, Sabbah HN, Kono T, Ali AS, Shimoyama H, Lesch M, Goldstein S: Ultrastructural abnormalities of cardiomyocytes in the border zone of old infarctions: studies in dogs with chronic heart failure (Abstr). FASEB J 7: A112, 1993Google Scholar

Copyright information

© Kluwer Academic Publishers 1995

Authors and Affiliations

  • Hani N. Sabbah
    • 1
  • Victor G. Sharov
    • 1
  • Michael Lesch
    • 1
  • Sidney Goldstein
    • 1
  1. 1.Department of Medicine, Division of Cardiovascular MedicineHenry Ford Heart and Vascular InstituteDetroitUSA
  2. 2.Henry Ford HospitalDetroitUSA

Personalised recommendations